Trigyn Technologies Limited is steering through a leadership transition as Dr. Satyam Cherukuri steps down from the top role. The company announced that Cherukuri, who has been serving as Chairman and Non-Executive Director, will resign from his positions effective Monday, April 7, 2026, due to personal commitments requiring his full attention. He will also relinquish his seat on the board of Trigyn Technologies Inc., the company’s subsidiary, from the same date.
In its note to the market, Trigyn expressed sincere appreciation for Cherukuri’s contributions during his tenure and signaled a commitment to a smooth and orderly transition of leadership. The board indicated it will work to ensure continuity and will brief his successor as part of the transition, underscoring a focus on stability for the company’s governance and strategic oversight going forward.
Cherukuri’s departure marks a notable moment for Trigyn’s governance, as the board navigates leadership dynamics and the ongoing execution of its strategic priorities. With the transition in motion, leadership experts will be watching how the company manages the changeover, preserves investor confidence, and maintains momentum across its technology services and related ventures.